Patzak Andreas, Bontscho Julia, Lai Enyin, Kupsch Eckehardt, Skalweit Angela, Richter Claus-Michael, Zimmermann Mathias, Thöne-Reineke Christa, Joehren Olaf, Godes Michael, Steege Andreas, Hocher Berthold
Johannes-Müller-Institut für Physiologie, Humboldt-Universität zu Berlin, Universitätsklinikum Charité, Tucholskystr. 2, 10117 Berlin.
Nephrol Dial Transplant. 2005 Dec;20(12):2681-9. doi: 10.1093/ndt/gfi136. Epub 2005 Sep 27.
Although endothelin I (ET-1) is a very potent vasoconstrictor, ET-1 transgenic (ET-1 tg) mice are not hypertensive. This might be due to higher bioavailability of nitric oxide (NO) in ET-1 tg, which counteracts the effect of vasoconstrictors. We hypothesized lower angiotensin II (Ang II) sensitivity of afferent arterioles in ET-1 tg.
Afferent arterioles were manually dissected and microperfused. Changes of the luminal diameter due to application of vasoactive substances were used for assessment of the reactivity of afferent arterioles. We investigated the effect of L-NAME, an unspecific NO synthase inhibitor, on basal tone, and the sensitivity of afferent arterioles to Ang II with and without pre-treatment with L-NAME. The renin-angiotensin-system was characterized by expression analysis of angiotensin-receptors and renin at the mRNA level.
L-NAME reduced afferent arterioles diameters similarly in ET-1 tg and wild-types (WT). Ang II sensitivity determined by calculation of EC50 for Ang II was less in ET-1 tg compared with WT (P<0.05). Ang II reduced luminal diameters to a lesser extent in ET-1 tg compared to WT (P<0.05). After pre-treatment with L-NAME, Ang II sensitivity and maximum constriction of afferent arterioles were similar in ET-1 tg and WT. The expression of renin- and Ang II-receptor-mRNA in the kidney did not differ between either group.
The loss of differences in the maximum constriction and Ang II sensitivity of afferent arterioles between ET-1 tg and WT in the absence of NO suggests pronounced NO effects in afferent arterioles of ET-1 tg. This might contribute to the maintenance of normal renal arteriolar tone in ET-1 tg mice.
尽管内皮素I(ET-1)是一种非常强效的血管收缩剂,但ET-1转基因(ET-1 tg)小鼠并无高血压。这可能是由于ET-1 tg中一氧化氮(NO)的生物利用度较高,它可抵消血管收缩剂的作用。我们推测ET-1 tg中传入小动脉对血管紧张素II(Ang II)的敏感性较低。
手动解剖并对传入小动脉进行微灌注。应用血管活性物质引起的管腔直径变化用于评估传入小动脉的反应性。我们研究了非特异性NO合酶抑制剂L-NAME对基础张力的影响,以及在有或无L-NAME预处理情况下传入小动脉对Ang II的敏感性。通过在mRNA水平对血管紧张素受体和肾素进行表达分析来表征肾素-血管紧张素系统。
L-NAME使ET-1 tg和野生型(WT)小鼠的传入小动脉直径同样减小。通过计算Ang II的半数有效浓度(EC50)确定的Ang II敏感性,ET-1 tg低于WT(P<0.05)。与WT相比,Ang II使ET-1 tg的管腔直径减小程度较小(P<0.05)。用L-NAME预处理后,ET-1 tg和WT小鼠传入小动脉的Ang II敏感性和最大收缩程度相似。两组肾脏中肾素和Ang II受体mRNA的表达无差异。
在不存在NO的情况下,ET-1 tg和WT小鼠传入小动脉最大收缩和Ang II敏感性的差异消失,提示NO在ET-1 tg的传入小动脉中有显著作用。这可能有助于维持ET-1 tg小鼠肾小动脉的正常张力。